Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Wyatt

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
British Journal of Pharmacology|July 1, 1995
[3H]-lifarizine, a high affinity probe for inactivated sodium channelsA C MacKinnon, K M Wyatt, J G McGivern, et al.
Journal of Inherited Metabolic Disease|February 13, 2014
The NCS-LSD cohort study: a description of the methods and analyses used to assess the long-term effectiveness of enzyme replacement therapy and substrate reduction therapy in patients with lysosomal storage disordersW E Henley, L J Anderson, K M Wyatt, et al.
Journal of Inherited Metabolic Disease|February 12, 2014
Long-term effectiveness of enzyme replacement therapy in adults with Gaucher disease: results from the NCS-LSD cohort studyL J Anderson, W Henley, K M Wyatt, et al.
Journal of Inherited Metabolic Disease|March 19, 2014
Long-term effectiveness of enzyme replacement therapy in children with Gaucher disease: results from the NCS-LSD cohort studyL J Anderson, W Henley, K M Wyatt, et al.
Journal of Inherited Metabolic Disease|June 8, 2014
Effectiveness of enzyme replacement therapy in adults with late-onset Pompe disease: results from the NCS-LSD cohort studyL J Anderson, W Henley, K M Wyatt, et al.
Journal of Inherited Metabolic Disease|May 17, 2014
Long-term effectiveness of enzyme replacement therapy in Fabry disease: results from the NCS-LSD cohort studyL J Anderson, K M Wyatt, W Henley, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
British Journal of Pharmacology|July 1, 1995
[3H]-lifarizine, a high affinity probe for inactivated sodium channelsA C MacKinnon, K M Wyatt, J G McGivern, et al.
Journal of Inherited Metabolic Disease|February 13, 2014
The NCS-LSD cohort study: a description of the methods and analyses used to assess the long-term effectiveness of enzyme replacement therapy and substrate reduction therapy in patients with lysosomal storage disordersW E Henley, L J Anderson, K M Wyatt, et al.
Journal of Inherited Metabolic Disease|February 12, 2014
Long-term effectiveness of enzyme replacement therapy in adults with Gaucher disease: results from the NCS-LSD cohort studyL J Anderson, W Henley, K M Wyatt, et al.
Journal of Inherited Metabolic Disease|March 19, 2014
Long-term effectiveness of enzyme replacement therapy in children with Gaucher disease: results from the NCS-LSD cohort studyL J Anderson, W Henley, K M Wyatt, et al.
Journal of Inherited Metabolic Disease|June 8, 2014
Effectiveness of enzyme replacement therapy in adults with late-onset Pompe disease: results from the NCS-LSD cohort studyL J Anderson, W Henley, K M Wyatt, et al.
Journal of Inherited Metabolic Disease|May 17, 2014
Long-term effectiveness of enzyme replacement therapy in Fabry disease: results from the NCS-LSD cohort studyL J Anderson, K M Wyatt, W Henley, et al.
Pageof 2